Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Posner

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancerR R Weichselbaum, M R Posner, T J Ervin, et al.
Cancer|December 1, 1982
Chemotherapy of advanced salivary gland neoplasmsM R Posner, T J Ervin, R R Weichselbaum, et al.
Cancer Research|April 1, 1989
Human monoclonal antibodies reactive with human myelomonocytic leukemia cellsM R Posner, D J Santos, H S Elboim, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residuesR D Huhn, M R Posner, S I Rayter, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Plasma pharmacokinetics and biological activity of a human immunodeficiency virus type 1 neutralizing human monoclonal antibody, F105, in cynomolgus monkeysL A Cavacini, J Power, C L Emes, et al.
Human Antibodies and Hybridomas|April 1, 1991
An IgG human monoclonal antibody reactive with a surface membrane antigen expressed on malignant breast cancer cellsM R Posner, H S Elboim, M B Tumber, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patientsK K Graham, D J Mikolich, A E Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infectionM R Posner, T Hideshima, T Cannon, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1993
Human monoclonal antibodies to the V3 loop of HIV-1 gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding siteL A Cavacini, C L Emes, J Power, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neckA D Colevas, S Adak, P C Amrein, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|May 1, 1982
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancerR R Weichselbaum, M R Posner, T J Ervin, et al.
Cancer|December 1, 1982
Chemotherapy of advanced salivary gland neoplasmsM R Posner, T J Ervin, R R Weichselbaum, et al.
Cancer Research|April 1, 1989
Human monoclonal antibodies reactive with human myelomonocytic leukemia cellsM R Posner, D J Santos, H S Elboim, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residuesR D Huhn, M R Posner, S I Rayter, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1994
Plasma pharmacokinetics and biological activity of a human immunodeficiency virus type 1 neutralizing human monoclonal antibody, F105, in cynomolgus monkeysL A Cavacini, J Power, C L Emes, et al.
Human Antibodies and Hybridomas|April 1, 1991
An IgG human monoclonal antibody reactive with a surface membrane antigen expressed on malignant breast cancer cellsM R Posner, H S Elboim, M B Tumber, et al.
Journal of Acquired Immune Deficiency Syndromes|June 1, 1994
Pharmacologic evaluation of megestrol acetate oral suspension in cachectic AIDS patientsK K Graham, D J Mikolich, A E Fisher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infectionM R Posner, T Hideshima, T Cannon, et al.
Journal of Acquired Immune Deficiency Syndromes|April 1, 1993
Human monoclonal antibodies to the V3 loop of HIV-1 gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding siteL A Cavacini, C L Emes, J Power, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neckA D Colevas, S Adak, P C Amrein, et al.
Pageof 11